Clinical Trial 549

Birmingham, AL 35203

Study Summary:

Study evaluating the safety and therapeutic value of a new treatment for Type II Diabetes.

Qualified Participants Must:

• Must sign informed consent
• Must be diagnosed with new onset DM type II with in last one month
• Must be be male or female, aged 18 to 75yrs, inclusive
• FBG level must be between >140mg/dl and 270mg/dl.
• Fasting TG level >150mg/dl and <500mg/dl
• BMI of 22 to 40kg/m2

Qualified Participants May Receive:

Appropriately for time and travel

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.